Dataset Information


Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.

ABSTRACT: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may result in the multisystem inflammatory syndrome in children (MIS-C). The clinical presentation of MIS-C includes fever, severe illness, and the involvement of two or more organ systems, in combination with laboratory evidence of inflammation and laboratory or epidemiologic evidence of SARS-CoV-2 infection. Some features of MIS-C resemble Kawasaki Disease, toxic shock syndrome, and secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome. The relationship of MIS-C to SARS-CoV-2 infection suggests that the pathogenesis involves post-infectious immune dysregulation. Patients with MIS-C should ideally be managed in a pediatric intensive care environment since rapid clinical deterioration may occur. Specific immunomodulatory therapy depends on the clinical presentation. The relationship between the immune response to SARS-CoV-2 vaccines in development and MIS-C requires further study.


PROVIDER: S-EPMC7401880 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7444298 | BioStudies
2020-01-01 | S-EPMC7359537 | BioStudies
2020-01-01 | S-EPMC7649656 | BioStudies
2021-11-25 | PXD029375 | Pride
2020-01-01 | S-EPMC7489877 | BioStudies
2022-03-20 | GSE178491 | GEO
2020-01-01 | S-EPMC7797745 | BioStudies
2020-01-01 | S-EPMC7346766 | BioStudies
2020-01-01 | S-EPMC7585495 | BioStudies
2020-01-01 | S-EPMC7480058 | BioStudies